Skip to main navigation Skip to search Skip to main content

Protein-altering germline mutations implicate novel genes related to lung cancer development

  • Xuemei Ji
  • , Semanti Mukherjee
  • , Maria Teresa Landi
  • , Yohan Bosse
  • , Philippe Joubert
  • , Dakai Zhu
  • , Ivan Gorlov
  • , Xiangjun Xiao
  • , Younghun Han
  • , Olga Gorlova
  • , Rayjean J. Hung
  • , Yonathan Brhane
  • , Robert Carreras-Torres
  • , David C. Christiani
  • , Neil Caporaso
  • , Mattias Johansson
  • , Geoffrey Liu
  • , Stig E. Bojesen
  • , Loic Le Marchand
  • , Demetrios Albanes
  • Heike Bickeböller, Melinda C. Aldrich, William S. Bush, Adonina Tardon, Gad Rennert, Chu Chen, Jinyoung Byun, Konstantin H. Dragnev, John K. Field, Lambertus Fa Kiemeney, Philip Lazarus, Shan Zienolddiny, Stephen Lam, Matthew B. Schabath, Angeline S. Andrew, Pier A. Bertazzi, Angela C. Pesatori, Nancy Diao, Li Su, Lei Song, Ruyang Zhang, Natasha Leighl, Jakob S. Johansen, Anders Mellemgaard, Walid Saliba, Christopher Haiman, Lynne Wilkens, Ana Fernandez-Somoano, Guillermo Fernandez-Tardon, Erik H.F.M.van der Heijden, Jin Hee Kim, Michael P.A. Davies, Michael W. Marcus, Hans Brunnström, Jonas Manjer, Olle Melander, David C. Muller, Kim Overvad, Antonia Trichopoulou, Rosario Tumino, Gary E. Goodman, Angela Cox, Fiona Taylor, Penella Woll, Erich Wichmann, Thomas Muley, Angela Risch, Albert Rosenberger, Kjell Grankvist, Mikael Johansson, Frances Shepherd, Ming Sound Tsao, Susanne M. Arnold, Eric B. Haura, Ciprian Bolca, Ivana Holcatova, Vladimir Janout, Milica Kontic, Jolanta Lissowska, Anush Mukeria, Simona Ognjanovic, Tadeusz M. Orlowski, Ghislaine Scelo, Beata Swiatkowska, David Zaridze, Per Bakke, Vidar Skaug, Lesley M. Butler, Kenneth Offit, Preethi Srinivasan, Chaitanya Bandlamudi, Matthew D. Hellmann, David B. Solit, Mark E. Robson, Charles M. Rudin, Zsofia K. Stadler, Barry S. Taylor, Michael F. Berger, Richard Houlston, John McLaughlin, Victoria Stevens, David C. Nickle, Ma’en Obeidat, Wim Timens, María Soler Artigas, Sanjay Shete, Hermann Brenner, Stephen Chanock, Paul Brennan, James D. McKay, Christopher I. Amos
  • Dartmouth College
  • Memorial Sloan-Kettering Cancer Center
  • National Institutes of Health
  • Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval
  • Baylor College of Medicine
  • University of Toronto
  • International Agency for Research on Cancer
  • Harvard University
  • Massachusetts General Hospital
  • University of Copenhagen
  • University of Hawai'i at Mānoa
  • University of Göttingen
  • Vanderbilt University
  • Case Western Reserve University
  • University of Oviedo
  • Clalit Health Services
  • Fred Hutchinson Cancer Research Center
  • Dartmouth Medical School Norris Cotton Cancer Center
  • University of Liverpool
  • Radboud University Nijmegen
  • National Institute of Occupational Health
  • Provincial Health Services Authority
  • Moffitt Cancer Center
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan
  • University Health Network
  • University of Southern California
  • Sejong University
  • Lund University
  • Imperial College London
  • Helenic Health Foundation
  • “Civic - M.P. Arezzo” Hospital
  • Swedish Medical Group
  • University of Sheffield
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Heidelberg University 
  • Translational Lung Research Center Heidelberg (TLRC-H)
  • University of Salzburg
  • Umeå University
  • University of Kentucky
  • Institute of Pneumology “Marius Nasta”
  • Charles University
  • Palacký University Olomouc
  • University of Belgrade
  • Maria Sklodowska-Curie Institute of Oncology
  • Russian N.N. Blokhin Cancer Research Centre
  • International Organization for Cancer Prevention and Research
  • National Institute of Tuberculosis and Lung Diseases
  • Nofer Institute of Occupational Medicine
  • University of Bergen
  • University of Pittsburgh
  • The Institute of Cancer Research
  • American Cancer Society
  • Merck
  • The University of British Columbia Centre for Heart Lung Innovation
  • University of Groningen
  • University of Leicester
  • University Hospitals of Leicester NHS Trust
  • University of Texas MD Anderson Cancer Center
  • German Cancer Research Center
  • Dan L. Duncan Cancer Center

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals of European ancestry and investigated gene expression levels in 7,773 samples. We find a large-effect association with an ATM L2307F (rs56009889) mutation in adenocarcinoma for discovery (adjusted Odds Ratio = 8.82, P = 1.18 × 10−15) and replication (adjusted OR = 2.93, P = 2.22 × 10−3) that is more pronounced in females (adjusted OR = 6.81 and 3.19 and for discovery and replication). We observe an excess loss of heterozygosity in lung tumors among ATM L2307F allele carriers. L2307F is more frequent (4%) among Ashkenazi Jewish populations. We also observe an association in discovery (adjusted OR = 2.61, P = 7.98 × 10−22) and replication datasets (adjusted OR = 1.55, P = 0.06) with a loss-of-function mutation, Q4X (rs150665432) of an uncharacterized gene, KIAA0930. Our findings implicate germline genetic variants in ATM with lung cancer susceptibility and suggest KIAA0930 as a novel candidate gene for lung cancer risk.

Original languageEnglish
Article number2220
JournalNature Communications
Volume11
Issue number1
DOIs
StatePublished - Dec 1 2020

Fingerprint

Dive into the research topics of 'Protein-altering germline mutations implicate novel genes related to lung cancer development'. Together they form a unique fingerprint.

Cite this